Actimus Bio - About the company
Actimus Bio is a deadpooled company based in Visakhapatnam (India), founded in 2004. It operates as a CRO offering drug discovery and BA/BE services. The company has 390 active competitors, including 35 funded and 59 that have exited. Its top competitors include companies like LabCorp, Charles River Laboratories and Precision for Medicine.
Company Details
ActimusBio is a CRO having 2 major services divisions - Clinical Research and Chemistry Research. Through their Chemistry Research division, they offer services such as custom synthesis, medicinal chemistry (ligand/receptor binding; enzyme inhibition, SAR studies, QSAR analyses, de novo drug design etc) and process development (Mechanistic and Kinetic Studies, Critical Process Parameters and Quality Attributes). They also offer services such as target identification and validation, lead generation and optimisation, and molecular ADME/toxicology predictive modelling. Through their clinical research services division, they offer BA/BE studies and individual services such as study design, project management, medical safety monitoring, biostatistics, quality assurance auditing, regulatory submissions etc. The company also has a diagnostics lab with equipment like Beckman Coulter cell counters and ELISA readers.
- Website
- actimusbio.com
- Registered Address
- 4TH FLOOR, VARUN TOWERS,7-8-1/3, KASTURIGBA MARG, SIRIPURAM, VISAKHAPATNAM, Andhra Pradesh, India, 530003
Key Metrics
Founded Year
2004
Location
Visakhapatnam, India
Stage
Deadpooled
Ranked
130th among 390 active competitors
Annual Revenue
₹50 - ₹100 Cr as on Mar 31, 2025
Employee Count
51 - 200 as on Jul 01, 2024
Legal entities associated with Actimus Bio
Actimus Bio is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
ACTIMUS BIOSCIENCES PRIVATE LIMITED CIN: U74140AP2004PTC042512 , India, Active | Jan 28, 2004 | ₹50 - ₹100 Cr (As on Mar 31, 2025) | 245 (As on Aug 01, 2025) |
Sign up to download Actimus Bio's company profile
Actimus Bio's funding and investors
Actimus Bio has not raised any funding rounds yet.
Actimus Bio's founders and board of directors
Founder? Claim ProfileActimus Bio's employee count trend
Actimus Bio has 51 - 200 employees as of Jul 24. Here is Actimus Bio's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Actimus Bio's Competitors and alternates
Top competitors of Actimus Bio include LabCorp, Charles River Laboratories and Precision for Medicine. Here is the list of Top 10 competitors of Actimus Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | LabCorp 1969, Burlington (United States), Public | Provider of laboratory tests for physicians | - | 78/100 | |
2nd | Charles River Laboratories 1947, Wilmington (United States), Public | Provider of drug discovery and preclinical development services | - | 66/100 | |
3rd | Precision for Medicine 2013, United States, Late Stage | Provider of clinical research services, laboratory services, and data intelligence | $150M | 63/100 | |
4th | Veeda Lifesciences 2004, Ahmedabad (India), Series B | Provider of clinical research services for drug development and testing | $83.3M | 62/100 | |
5th | Taimei Technology 2013, Pleasanton (United States), Public | A digital intelligence platform focused on the life sciences sector | $194M | 60/100 | |
6th | Frontage Laboratories 2001, Exton (United States), Public | Global pharmaceutical development organization providing comprehensive drug discovery and development services | $10.2M | 57/100 | |
7th | Crystal Pharmatech 2010, Suzhou (China), Series B | Provider of solid state research services for small molecules | $24.5M | 57/100 | |
8th | Medimaps Group 2006, Geneva (Switzerland), Series B | Developer of AI-powered bone health assessment software | $20M | 54/100 | |
9th | Cytel 1987, Cambridge (United States), Acquired | Provider of data analysis and statistical solutions for the life sciences industry | $2M | 53/100 | |
10th | InduPro 2022, Seattle (United States), Series A | Provides science to manipulate protein interactions and explore new possibilities for treating patients | $85M | 50/100 | |
130th | Actimus Bio 2004, Visakhapatnam (India), Deadpooled | CRO offering drug discovery and BA/BE services | - | - | 26/100 |
Looking for more details on Actimus Bio's competitors? Click here to see the top ones
Actimus Bio's Investments and acquisitions
Actimus Bio has made no investments or acquisitions yet.
Reports related to Actimus Bio
Here is the latest report on Actimus Bio's geography:
Are you a Founder ?
FAQs about Actimus Bio
Explore our recently published companies
- Sum Technology - Petaling Jaya based, 2013 founded, Public company
- Rezna - United States based, 2026 founded, Unfunded company
- Moerkantheide - Unfunded company
- Gebaeudereinigung-Jasarov - Unfunded company
- Kosmetikstudio-Windsbach - Unfunded company
- Hammerundneuderth - Unfunded company